These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Trifluorinated Pyrimidine-Based A Mallo-Abreu A; Majellaro M; Jespers W; Azuaje J; Caamaño O; García-Mera X; Brea JM; Loza MI; Gutiérrez-de-Terán H; Sotelo E J Med Chem; 2019 Oct; 62(20):9315-9330. PubMed ID: 31557025 [TBL] [Abstract][Full Text] [Related]
4. Identification of V6.51L as a selectivity hotspot in stereoselective A Wang X; Jespers W; Prieto-Díaz R; Majellaro M; IJzerman AP; van Westen GJP; Sotelo E; Heitman LH; Gutiérrez-de-Terán H Sci Rep; 2021 Jul; 11(1):14171. PubMed ID: 34238993 [TBL] [Abstract][Full Text] [Related]
5. Nitrogen-Walk Approach to Explore Bioisosteric Replacements in a Series of Potent A Mallo-Abreu A; Prieto-Díaz R; Jespers W; Azuaje J; Majellaro M; Velando C; García-Mera X; Caamaño O; Brea J; Loza MI; Gutiérrez-de-Terán H; Sotelo E J Med Chem; 2020 Jul; 63(14):7721-7739. PubMed ID: 32573250 [TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel xanthine derivatives as potent and selective A Basu S; Barawkar DA; Ramdas V; Patel M; Waman Y; Panmand A; Kumar S; Thorat S; Naykodi M; Goswami A; Reddy BS; Prasad V; Chaturvedi S; Quraishi A; Menon S; Paliwal S; Kulkarni A; Karande V; Ghosh I; Mustafa S; De S; Jain V; Banerjee ER; Rouduri SR; Palle VP; Chugh A; Mookhtiar KA Eur J Med Chem; 2017 Jul; 134():218-229. PubMed ID: 28415011 [TBL] [Abstract][Full Text] [Related]
7. Irreversible Antagonists for the Adenosine A Temirak A; Schlegel JG; Voss JH; Vaaßen VJ; Vielmuth C; Claff T; Müller CE Molecules; 2022 Jun; 27(12):. PubMed ID: 35744918 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists. Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332 [TBL] [Abstract][Full Text] [Related]
9. Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A(1) adenosine receptor ligands. Giovannoni MP; Vergelli C; Cilibrizzi A; Crocetti L; Biancalani C; Graziano A; Dal Piaz V; Loza MI; Cadavid MI; Díaz JL; Gavaldà A Bioorg Med Chem; 2010 Nov; 18(22):7890-9. PubMed ID: 20937560 [TBL] [Abstract][Full Text] [Related]
10. Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists. Müller CE; Geis U; Grahner B; Lanzner W; Eger K J Med Chem; 1996 Jun; 39(13):2482-91. PubMed ID: 8691445 [TBL] [Abstract][Full Text] [Related]
11. The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling. Vecchio EA; Chuo CH; Baltos JA; Ford L; Scammells PJ; Wang BH; Christopoulos A; White PJ; May LT Biochem Pharmacol; 2016 Oct; 117():46-56. PubMed ID: 27520486 [TBL] [Abstract][Full Text] [Related]
12. Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes. El Maatougui A; Azuaje J; González-Gómez M; Miguez G; Crespo A; Carbajales C; Escalante L; García-Mera X; Gutiérrez-de-Terán H; Sotelo E J Med Chem; 2016 Mar; 59(5):1967-83. PubMed ID: 26824742 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationship of pyrazolo[3,4-d]pyrimidines: potent and selective adenosine A1 receptor antagonists. Poulsen SA; Quinn RJ J Med Chem; 1996 Oct; 39(21):4156-61. PubMed ID: 8863792 [TBL] [Abstract][Full Text] [Related]
14. Structure-affinity relationships of adenosine A2B receptor ligands. Beukers MW; Meurs I; Ijzerman AP Med Res Rev; 2006 Sep; 26(5):667-98. PubMed ID: 16847822 [TBL] [Abstract][Full Text] [Related]
15. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigation. Pastorin G; Da Ros T; Spalluto G; Deflorian F; Moro S; Cacciari B; Baraldi PG; Gessi S; Varani K; Borea PA J Med Chem; 2003 Sep; 46(20):4287-96. PubMed ID: 13678407 [TBL] [Abstract][Full Text] [Related]
16. Beerkens BLH; Andrianopoulou V; Wang X; Liu R; van Westen GJP; Jespers W; IJzerman AP; Heitman LH; van der Es D ACS Chem Biol; 2024 Jul; 19(7):1554-1562. PubMed ID: 38920052 [TBL] [Abstract][Full Text] [Related]
17. Discovery and optimization of potent and selective functional antagonists of the human adenosine A2B receptor. Bedford ST; Benwell KR; Brooks T; Chen I; Comer M; Dugdale S; Haymes T; Jordan AM; Kennett GA; Knight AR; Klenke B; LeStrat L; Merrett A; Misra A; Lightowler S; Padfield A; Poullennec K; Reece M; Simmonite H; Wong M; Yule IA Bioorg Med Chem Lett; 2009 Oct; 19(20):5945-9. PubMed ID: 19733067 [TBL] [Abstract][Full Text] [Related]
18. Total Synthesis of Clerobungin A via a Cascade Cyclization Reaction. Mease J; Reber KP J Org Chem; 2016 Dec; 81(23):12006-12011. PubMed ID: 27934453 [TBL] [Abstract][Full Text] [Related]
19. Actinin-1 binds to the C-terminus of A2B adenosine receptor (A2BAR) and enhances A2BAR cell-surface expression. Sun Y; Hu W; Yu X; Liu Z; Tarran R; Ravid K; Huang P Biochem J; 2016 Jul; 473(14):2179-86. PubMed ID: 27208173 [TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity. Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]